Combivent Respimat® Inhaler for COPD Bronchospasm Relief

What Combivent Respimat® Is and How It Works

Combivent Respimat Inhaler is a prescription bronchodilator for adults with chronic obstructive pulmonary disease (COPD). It combines ipratropium bromide (an anticholinergic) and albuterol, also called salbutamol (a short-acting beta2-agonist). The two medicines open narrowed airways, reduce bronchospasm, and improve breathing. The soft-mist device delivers a fine aerosol without propellants for consistent dosing. Many people compare the Combivent Respimat Inhaler price to local options and choose to buy Combivent Respimat Inhaler online for convenience, including those paying without insurance.

YouDrugstore.com is a licensed Canadian pharmacy headquartered in Manitoba, and licensed pharmacists review prescriptions before dispensing.

We work with vetted, licensed international partner pharmacies so you receive authentic brand medications, a broad selection, and competitive pricing.

Indication: maintenance bronchodilation in COPD for patients who need a second bronchodilator. Route: oral inhalation using the Respimat device. Typical dosing cadence: one inhalation four times daily, with up to six inhalations in 24 hours if needed. It is not approved for asthma. Use only as directed by a healthcare professional.

Dosage and Usage

• Usual dose: 1 inhalation four times daily. Do not exceed 6 inhalations in 24 hours.
• First use: insert the cartridge into the Respimat, pushing firmly until it clicks into place.
• Prime the device: turn the clear base until it clicks, open the cap, point the inhaler downward, and press the dose-release button. Repeat until a visible mist appears, then repeat three more times.
• Daily use: turn the base until it clicks, open the cap, breathe out fully, seal lips around the mouthpiece, and while breathing in slowly and deeply, press the dose button. Hold your breath for 10 seconds or as long as comfortable, then breathe out.
• If unused for 3 days: release 1 priming spray. If unused for more than 21 days: repeat full priming until mist appears, then three more sprays.
• Missed dose: take the next dose when remembered unless it is almost time for the next scheduled dose. Do not double doses.
• Cleaning: once weekly, wipe the mouthpiece (including the metal port) with a damp cloth. Keep the cap closed when not in use.
• Device life: discard 3 months after cartridge insertion, or when the dose indicator reaches zero, whichever comes first.

• Storage: store at 15–30 °C (59–86 °F). Do not freeze. Keep the cap closed and the inhaler dry.
• Keep away from heat and direct sunlight. Do not puncture the cartridge. Do not store in a car or near stoves or radiators.
• Travel: carry your inhaler in a protective case in your carry-on. Avoid extreme temperatures. Keep a backup inhaler if traveling for more than 3 months.
• Keep out of reach of children. Track your doses to avoid running out unexpectedly.

Benefits and Savings

Combivent Respimat delivers dual bronchodilation in a single soft-mist inhaler. The anticholinergic and beta-agonist combination helps relax smooth muscle from two pathways. Many patients experience improved airflow within minutes and better symptom control across the day when used on a regular schedule.

Ordering from our Canadian online pharmacy often brings 60–80% savings compared with typical US prices. The cash price for Combivent Respimat Inhaler at YouDrugstore.com is listed in US dollars for clarity. Value is strong for those paying without insurance. Multi-month supplies can lower the per-month cost, and bulk promotions may apply.

Looking for extra savings? See our current offers and promotions; you may find a Combivent Respimat Inhaler coupon during select sale periods.

Side Effects and Safety

• Common effects: cough, dry mouth, throat irritation, hoarseness, headache, dizziness.
• Other possible effects: tremor, palpitations, nervousness, nausea, vomiting.
• Upper respiratory issues: sinusitis, bronchitis, increased sputum.
• Musculoskeletal: muscle cramps.
• Mouth and eyes: taste changes; eye irritation if mist contacts eyes.

Serious but less common risks include paradoxical bronchospasm, hypersensitivity reactions, glaucoma worsening if the mist enters the eyes, urinary retention (especially with prostatic hyperplasia or bladder-neck obstruction), and cardiovascular effects such as increased heart rate or blood pressure. Avoid spraying into the eyes. Seek urgent care for sudden worsening of breathing, chest pain, or signs of an allergic reaction.

Onset Time

Bronchodilation from the albuterol component begins within minutes. Many patients notice easier breathing within 5–15 minutes of a dose. Peak effects often occur within 1–2 hours. Regular, scheduled use supports steadier symptom control, and improvements in activity tolerance may build over 1–2 weeks as the regimen stabilizes.

Compare With Alternatives

Short-acting single agents such as albuterol alone provide rapid relief but do not include the added anticholinergic action of ipratropium. Combivent Respimat combines both, which can offer greater bronchodilation than either component alone in COPD.

Inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) combinations are used for maintenance therapy in COPD and asthma. Examples include Symbicort® and Advair® Diskus. These options reduce exacerbations when indicated but are not intended for rapid relief of acute bronchospasm. Device formats and dosing schedules differ.

Long-acting muscarinic antagonists (LAMA) such as tiotropium are another maintenance path. A healthcare professional may select a LAMA, an ICS/LABA, or triple therapy based on symptoms, exacerbation risk, and spirometry. Combivent Respimat may be used for scheduled relief in patients who need both short-acting bronchodilators.

Combination Therapy

• With maintenance LAMA therapy: some patients use a LAMA daily and keep Combivent Respimat for scheduled short-acting use.
• With ICS/LABA maintenance: an ICS/LABA may be used for inflammation control, while Combivent Respimat provides short-acting bronchodilation.
• Avoid duplicate short-acting beta-agonists: combining with other SABAs can increase side effects such as tremor and palpitations.
• Caution with other anticholinergics: using multiple anticholinergics can increase dry mouth, constipation, and urinary retention.
• Monitor cardiovascular conditions: beta-agonists may affect heart rate and blood pressure; clinicians may adjust regimens accordingly.

Patient Suitability and Cost-Saving Tips

Combivent Respimat is prescribed for adult COPD, including chronic bronchitis or emphysema, who need two short-acting bronchodilators. It is not approved for children. People with narrow-angle glaucoma, urinary retention, prostatic hyperplasia, bladder-neck obstruction, arrhythmias, ischemic heart disease, hyperthyroidism, or seizure disorders may require closer monitoring.

Not suitable for anyone with a hypersensitivity to ipratropium, atropine and its derivatives, albuterol, or formulation excipients. Report eye pain, vision changes, difficulty urinating, or rapid heartbeat. Pregnancy and breastfeeding considerations should be reviewed with a healthcare professional to weigh risks and benefits.

To manage ongoing therapy costs, consider ordering a 90-day supply when appropriate. This can reduce per-month expense and cut down on shipping fees. Turn on reorder reminders in your account so you do not run out. Those paying out of pocket Combivent Respimat Inhaler costs can compare options and select the best price presented on the product page.

Authoritative Sources

Manufacturer product site for Combivent Respimat (Boehringer Ingelheim)

FDA Prescribing Information for Combivent Respimat

Health Canada Drug Product Database

Order Combivent Respimat® Inhaler from YouDrugstore.com: add to cart, upload your prescription, and we ship with prompt, express, cold-chain handling.

This content is for educational purposes and does not replace advice from your healthcare professional.